Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

#WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen …

Sectors: Biotechnology

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical

[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing …

Sectors: Health

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. We design our products and services to serve the most essential human needs of health and nutrition. At the same time, we strive to address some of the world’s biggest challenges presented by a growing and aging global population. At Bayer, we’re committed to driving sustainable development and generate a positive impact with our businesses. Through the power of science, we’re pioneering new possibilities that advance life for all of us. That means reimagining how we care for ourselves and one another by …

Tags: DAX30 Sectors: Chemistry Pharmaceutical

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, …

Sectors: Pharmaceutical

At IBM, we do more than work. We create. We create as technologists, developers, and engineers. We create with our partners. We create with our competitors. If you're searching for ways to make the world work better through technology and infrastructure, software and consulting, then we want to work with you. We're here to help every creator turn their "what if" into what is. Let's create something that will change everything. Cloud, Mobile, Cognitive, Security, Research, Watson, Analytics, Consulting, Commerce, Experience Design, Internet of Things, Technology support, Industry solutions, Systems services, Resiliency services, Financing, and IT infrastructure

Sectors: IT services

[Automatic translation follows] 14 varied and complementary establishments are the Paris-Saclay University: 3 universities *, 4 grandes écoles ** and 7 research organizations ***. In total, we represent 48,000 students, 9,000 researchers and teacher-researchers, 4,600 doctoral students and 275 laboratories. 14 Various goal complementary institutions Make up University Paris-Saclay: 3 universities *, 4 Prestigious University-Level Colleges ** and 7 Research Organizations ***. WE represent 9,000 profits and researchers, 4,600 PhD Students, 275 Laboratories and 48,000 students. * University Paris-Sud, University Versailles St-Quentin-en-Yvelines and University of Evry. ** Graduate School Optical Institute, Agroparistech, CentralsUpelec, Normal School Paris-Saclay. *** CEA, CNRS, IHES, …

Sectors: Research